|
|
Name: |
VIKING GLOBAL INVESTORS LP |
City: |
NEW YORK |
State: |
NY |
Zip: |
10017 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
13 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
BBIO |
Bridgebio Pharma, Inc. |
9 |
- |
$28.98 |
$776,741,000 |
25,120,991 |
2.89% |
-237,393,000 |
0 |
14.44 |
N/A |
|
ROIV |
Roivant Sciences Ltd. |
10 |
- |
$10.86 |
$731,149,000 |
69,368,961 |
2.72% |
-47,864,000 |
0 |
10.024 |
N/A |
|
INBX |
Inhibrx, Inc. |
34 |
- |
$0.00 |
$249,993,000 |
7,150,826 |
0.93% |
-21,738,000 |
0 |
15.093 |
N/A |
|
NAMS |
Newamsterdam Pharma Ord Shs |
38 |
- |
$0.00 |
$189,781,000 |
8,024,565 |
0.71% |
100,147,000 |
0 |
9.839 |
N/A |
|
DNA |
Ginkgo Bioworks Holdings, Inc |
40 |
- |
$0.54 |
$165,979,000 |
143,085,126 |
0.62% |
-75,835,000 |
0 |
10.758 |
N/A |
|
ADPT |
Adaptive Biotechnologies Corp |
54 |
- |
$3.31 |
$96,280,000 |
29,993,708 |
0.36% |
-50,689,000 |
0 |
20.718 |
N/A |
|
DAWN |
Day One Biopharmaceuticals,... |
73 |
- |
$0.00 |
$42,267,000 |
2,558,563 |
0.16% |
4,912,000 |
0 |
2.94 |
N/A |
|
VSTM |
Verastem, Inc. |
76 |
- |
$3.94 |
$28,984,000 |
2,456,292 |
0.11% |
8,990,000 |
0 |
9.736 |
Biotechnology |
|
CZOO |
Cazoo Group |
77 |
- |
$0.20 |
$25,713,000 |
2,142,728 |
0.1% |
5,357,000 |
0 |
0.238 |
N/A |
|
PEPG |
Pepgen Inc. |
78 |
- |
$16.76 |
$21,792,000 |
1,482,434 |
0.08% |
11,711,000 |
0 |
6.274 |
N/A |
|
TRVI |
Trevi Therapeutics, Inc. |
80 |
- |
$0.00 |
$15,180,000 |
4,400,000 |
0.06% |
9,284,000 |
0 |
7.343 |
N/A |
|
RLYB |
Rallybio Corp |
82 |
- |
$0.00 |
$7,760,000 |
4,194,777 |
0.03% |
-2,266,000 |
0 |
12.152 |
N/A |
|
KNTE |
Kinnate Biopharma Inc. |
83 |
- |
$0.00 |
$4,842,000 |
1,820,462 |
0.02% |
528,000 |
0 |
4.165 |
N/A |
|